STREAMING NOW: Watch Now

US FDA announces emergency authorization for convalescent plasma to treat Covid-19

The US Food and Drug Administration on Sunday issued an emergency use authorization for convalescent plasma to treat Covid-19, saying the "known and potentia...

Posted: Aug 24, 2020 7:18 AM

The US Food and Drug Administration on Sunday issued an emergency use authorization for convalescent plasma to treat Covid-19, saying the "known and potential benefits of the product outweigh the known and potential risks of the product."

The FDA said more than 70,000 patients had been treated with convalescent plasma,which is made using the blood of people who have recovered from coronavirus infections.

"Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives," President Trump said at a White House briefing, referring to the coronavirus that causes Covid-19. "Today's action will dramatically increase access to this treatment."

Last week, Trump accused some health officials of playing politics regarding an EUA for convalescent plasma. When asked about the FDA not having granted an EUA, Trump said the reason was political.

On Sunday, a source who is close to the White House Coronavirus Task Force told CNN the FDA had reviewed additional data to inform its EUA decision. This official has not personally reviewed the data. They added the FDA is under no obligation to consult anyone outside the agency about its decision.

Convalescent plasma is taken from the blood of people who have recovered from Covid-19. At the end of March, the FDA set up a pathway for scientists to try convalescent plasma with patients and study its impact. It has already been used to treat more than 60,000 Covid-19 patients.

However, like blood, convalescent plasma is in limited supply and must come from donors. And while there are promising signals from some studies, there is not yet randomized clinical trial data on convalescent plasma to treat Covid-19. Some of those trials are underway.

Experts say more data is needed

US Health and Human Services Secretary Alex Azar said studies involving 70,000 volunteers justified the EUA.

"The data we gathered suggests that patients who were treated early in their disease course, within three days of being diagnosed, with plasma containing high levels of antibodies, benefited the most from treatment. We saw about a 35% better survival in the patients who benefited most from the treatment," Azar told the White House briefing.

"We dream in drug development of something like a 35% mortality reduction. This is a major advance in the treatment of patients. A major advance."

Azar appeared to be referring to a national study of 35,000 patients treated with convalescent plasma. The study, released August 12 in a pre-print, meaning it had not yet been peer-reviewed, showed that 8.7% of patients who were treated within three days of diagnosis died, compared to about 12% of patients who were treated four days or more after their diagnosis. That's about a difference of about 37%.

Those treated with plasma containing the highest levels of antibodies had a 35% lower risk of dying within a week compared to those treated with less-rich plasma.

But this is not how doctors usually measure the benefit of a treatment. The gold standard is a randomized, placebo-controlled clinical trial that means that doctors randomly choose who gets the treatment and who doesn't, so they can truly tell whether it's the treatment affecting survival and not something else. And the comparison is usually treated patients compared to untreated patients -- not patients treated earlier compared to those treated later.

"The problem is, we don't really have enough data to really understand how effective convalescent plasma is," Dr. Jonathan Reiner, a professor of medicine at George Washington University and a CNN medical analyst, said Sunday.

"While the data to date show some positive signals that convalescent plasma can be helpful in treating individuals with COVID-19, especially if given early in the trajectory of disease, we lack the randomized controlled trial data we need to better understand its utility in COVID-19 treatment," Dr. Thomas File, president of the Infectious Diseases Society of America, said in a statement.

Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, said he thought it likely the White House pressured the FDA into pushing through the EUA.

"I think what's happening here is you're seeing bullying, at least at the highest level of the FDA, and I'm sure that there are people at the FDA right now who are the workers there that are as upset about this as I am," Offit told CNN's Wolf Blitzer.

According to a knowledgeable source, Dr. Francis Collins, head of the National Institutes of Health; Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and Dr. H. Clifford Lane, who works under Fauci at NIAID, were among government health officials who had previously been skeptical there was enough data to justify emergency authorization of plasma for Covid-19.

'Great demand from patients and doctors'

President Trump said there might have been a holdup on the EUA, "but we broke the logjam over the last week to be honest," Trump said at the briefing. He said he believed there were officials at the FDA and in the Department of Health and Human Services "that can see things being held up and wouldn't mind so much."

"It's my opinion, very strong opinion, and that's for political reasons," Trump said.

Hahn denied the decision was made for any other than legitimate medical reasons.

"I took an oath as a doctor 35 years ago to do no harm. I abide by that every day," Hahn said in a statement to CNN's Jim Acosta.

"I've never been asked to make any decision at the FDA based on politics. The decisions the scientists at the FDA are making are done on data only."

Hahn said during the briefing the agency decided the treatment was safe, and looked potentially effective enough to justify the EUA, which is not the same as full approval.

"So we have ongoing clinical trials that are randomized between a placebo, or an inactive substance, and the convalescent plasma. While that was going on we knew there was great demand from patients and doctors," Hahn said.

While an EUA can open the treatment to more patients, it could also have the effect of limiting enrollment in clinical trials that determine whether it's effective.

On Thursday, Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said that doctors have treated so many Covid-19 patients with convalescent plasma, it has been difficult to figure out if the treatment works.

"The problem with convalescent plasma is the great enthusiasm about it," Woodcock said in an online conversation about the latest science behind monoclonal antibody treatments and convalescent plasma. "It exceeded anyone's expectation as far as the demand."

Bioethics expert Art Caplan said he's worried about whether there's a large enough supply of convalescent plasma. With an EUA, doctors will be more likely to give convalescent plasma without tracking data, so it will then be difficult to determine which donors have the most effective plasma, and which patients are the best candidates to receive it.

"We're going to get a gold rush towards plasma, with patients demanding it and doctors demanding it for their patients," said Caplan, the founding head of the Division of Medical Ethics at NYU School of Medicine.

Huntsville
Overcast
40° wxIcon
Hi: 40° Lo: 23°
Feels Like: 33°
Florence
Overcast
44° wxIcon
Hi: 38° Lo: 24°
Feels Like: 38°
Fayetteville
Overcast
36° wxIcon
Hi: 40° Lo: 24°
Feels Like: 28°
Decatur
Overcast
40° wxIcon
Hi: 40° Lo: 23°
Feels Like: 34°
Scottsboro
Overcast
41° wxIcon
Hi: 41° Lo: 26°
Feels Like: 38°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Alabama Coronavirus Cases

Cases: 244993

Reported Deaths: 3572
CountyCasesDeaths
Jefferson32314500
Mobile19859361
Madison13223148
Tuscaloosa13049154
Montgomery12342236
Shelby1031577
Baldwin873398
Lee775766
Morgan662650
Calhoun6301119
Etowah627666
Marshall627255
Houston525638
DeKalb485536
Cullman439442
Limestone425145
St. Clair419555
Lauderdale407854
Elmore406864
Walker3657111
Talladega351454
Jackson320423
Colbert311942
Blount292240
Autauga273542
Franklin252633
Coffee245415
Dale232654
Dallas226232
Chilton223438
Russell22193
Covington218934
Escambia198331
Chambers176850
Tallapoosa176391
Pike158614
Clarke158419
Marion140236
Winston133023
Lawrence127936
Pickens123518
Geneva12218
Marengo121524
Bibb117917
Barbour117310
Butler116541
Randolph102921
Cherokee102224
Hale97031
Clay91924
Fayette91616
Washington91219
Henry8546
Lowndes79929
Monroe78911
Cleburne77214
Macon73722
Crenshaw71130
Bullock69619
Perry6886
Conecuh68414
Lamar6798
Wilcox63518
Sumter58122
Greene42618
Choctaw42213
Coosa3444
Out of AL00
Unassigned00

Tennessee Coronavirus Cases

Cases: 363466

Reported Deaths: 4541
CountyCasesDeaths
Shelby47682658
Davidson42703420
Knox18764149
Rutherford17749161
Hamilton16701152
Williamson1140080
Sumner9744137
Out of TN758152
Wilson748178
Montgomery658683
Sullivan643996
Washington6000106
Putnam591382
Maury584267
Blount549160
Madison5349110
Bradley519735
Sevier484831
Unassigned468222
Robertson377453
Tipton365938
Hamblen345560
Gibson323365
Dyer320751
Greene308272
Anderson294629
Dickson289133
Coffee281841
Bedford275630
Carter272455
Lawrence270034
Obion265950
Cumberland257236
McMinn252355
Warren240020
Roane235229
Loudon228019
Jefferson226932
Fayette225338
Hardeman224737
Weakley216937
Monroe212744
Franklin208634
Lauderdale205023
Hawkins194934
Wayne192010
Trousdale190512
Henderson185133
Macon184028
Hardin178125
White176918
Carroll174734
Marshall174420
Rhea169731
Haywood162930
Lincoln161215
Cocke160630
Cheatham158617
Overton154335
Campbell154223
Henry153619
Giles146949
Smith143819
Johnson141621
McNairy140233
Fentress121920
Hickman118219
Lake11766
Bledsoe11745
DeKalb115822
Crockett115526
Marion109819
Scott10727
Chester102520
Grainger101217
Decatur95513
Unicoi85826
Claiborne8369
Benton81314
Grundy77714
Cannon7663
Lewis76314
Morgan7306
Union7195
Humphreys7098
Jackson68410
Polk66515
Stewart59415
Houston58720
Clay55318
Sequatchie5285
Meigs48913
Perry48321
Moore3963
Pickett39013
Van Buren3672
Hancock1673

Community Events